BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 30144445)

  • 61. Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor Vasculogenesis.
    Naz S; Leiker AJ; Choudhuri R; Preston O; Sowers AL; Gohain S; Gamson J; Mathias A; Van Waes C; Cook JA; Mitchell JB
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1295-1305. PubMed ID: 33838214
    [TBL] [Abstract][Full Text] [Related]  

  • 62. microRNA-124 inhibits stem-like properties and enhances radiosensitivity in nasopharyngeal carcinoma cells via direct repression of expression of JAMA.
    Tian Y; Tian Y; Tu Y; Zhang G; Zeng X; Lin J; Ai M; Mao Z; Zheng R; Yuan Y
    J Cell Mol Med; 2020 Sep; 24(17):9533-9544. PubMed ID: 32681617
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MiR-24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1.
    Kang M; Xiao J; Wang J; Zhou P; Wei T; Zhao T; Wang R
    Cancer Med; 2016 Jun; 5(6):1163-73. PubMed ID: 26922862
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.
    Zhang X; Yang X; Zhu S; Li Q; Zou N
    Oncol Rep; 2019 Mar; 41(3):1960-1970. PubMed ID: 30569171
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Homologous Recombination Repair Pathway is Associated with Resistance to Radiotherapy in Nasopharyngeal Carcinoma.
    Wang Z; Zuo W; Zeng Q; Li Y; Lu T; Bu Y; Hu G
    Int J Biol Sci; 2020; 16(3):408-419. PubMed ID: 32015678
    [TBL] [Abstract][Full Text] [Related]  

  • 66. SHP-1 overexpression increases the radioresistance of NPC cells by enhancing DSB repair, increasing S phase arrest and decreasing cell apoptosis.
    Pan X; Mou J; Liu S; Sun Z; Meng R; Zhou Z; Wu G; Peng G
    Oncol Rep; 2015 Jun; 33(6):2999-3005. PubMed ID: 25962492
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Silencing fibronectin extra domain A enhances radiosensitivity in nasopharyngeal carcinomas involving an FAK/Akt/JNK pathway.
    Ou J; Pan F; Geng P; Wei X; Xie G; Deng J; Pang X; Liang H
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e685-91. PubMed ID: 22208970
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
    Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Knockdown of NFBD1/MDC1 enhances chemosensitivity to cisplatin or 5-fluorouracil in nasopharyngeal carcinoma CNE1 cells.
    Zeng Q; Wang Z; Liu C; Gong Z; Yang L; Jiang L; Ma Z; Qian Y; Yang Y; Kang H; Hong S; Bu Y; Hu G
    Mol Cell Biochem; 2016 Jul; 418(1-2):137-46. PubMed ID: 27334757
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Metformin inhibits the growth of nasopharyngeal carcinoma cells and sensitizes the cells to radiation via inhibition of the DNA damage repair pathway.
    Li H; Chen X; Yu Y; Wang Z; Zuo Y; Li S; Yang D; Hu S; Xiang M; Xu Z; Yu Z
    Oncol Rep; 2014 Dec; 32(6):2596-604. PubMed ID: 25333332
    [TBL] [Abstract][Full Text] [Related]  

  • 71. lncRNA CASC19 Contributes to Radioresistance of Nasopharyngeal Carcinoma by Promoting Autophagy via AMPK-mTOR Pathway.
    Liu H; Zheng W; Chen Q; Zhou Y; Pan Y; Zhang J; Bai Y; Shao C
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573349
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Slug mediates nasopharyngeal carcinoma radioresistance via downregulation of PUMA in a p53-dependent and -independent manner.
    Xu T; Fan B; Lv C; Xiao D
    Oncol Rep; 2015 May; 33(5):2631-8. PubMed ID: 25812964
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of GADD45G on the radioresistance of nasopharyngeal carcinoma cells.
    Lou D; Zhu D; Wang Z; Zhang R; Yu Z; Gong F; Peng Y; Zeng S; Liu Y; Li A; Fan Q
    Anticancer Drugs; 2022 Jan; 33(1):e84-e93. PubMed ID: 34282742
    [TBL] [Abstract][Full Text] [Related]  

  • 74. RPA1 expression in esophageal carcinoma and its influence on radiosensitivity of esophageal carcinoma TE-1 cells.
    Zhang DJ; Xiang J; Wang X; Wang J; Xiao JC; Xu W; Xu H; Xin Y; Zhang LZ; Pei DS; Zheng JN; Gu YM
    Panminerva Med; 2015 Dec; 57(4):183-9. PubMed ID: 26824734
    [TBL] [Abstract][Full Text] [Related]  

  • 75. ARC is highly expressed in nasopharyngeal carcinoma and confers X-radiation and cisplatin resistance.
    Wu P; Tang Y; He J; Qi L; Jiang W; Zhao S
    Oncol Rep; 2013 Oct; 30(4):1807-13. PubMed ID: 23877130
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long non-coding RNA HNF1A-AS is upregulated and promotes cell proliferation and metastasis in nasopharyngeal carcinoma.
    Zhuang K; Wu Q; Jin CS; Yuan HJ; Cheng JZ
    Cancer Biomark; 2016; 16(2):291-300. PubMed ID: 26756620
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Downregulation of annexin A3 promotes ionizing radiation-induced EGFR activation and nuclear translocation and confers radioresistance in nasopharyngeal carcinoma.
    Yang L; Lu P; Yang X; Li K; Chen X; Zhou Y; Qu S
    Exp Cell Res; 2022 Sep; 418(2):113292. PubMed ID: 35850266
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Treatment of nasopharyngeal carcinoma cells with the histone-deacetylase inhibitor abexinostat: cooperative effects with cis-platin and radiotherapy on patient-derived xenografts.
    Gressette M; Vérillaud B; Jimenez-Pailhès AS; Lelièvre H; Lo KW; Ferrand FR; Gattolliat CH; Jacquet-Bescond A; Kraus-Berthier L; Depil S; Busson P
    PLoS One; 2014; 9(3):e91325. PubMed ID: 24618637
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
    Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
    J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.
    Liu ZH; Hu JL; Liang JZ; Zhou AJ; Li MZ; Yan SM; Zhang X; Gao S; Chen L; Zhong Q; Zeng MS
    Cell Death Dis; 2015 Oct; 6(10):e1920. PubMed ID: 26469968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.